Literature DB >> 34345360

Neuropsychological profile in the preclinical stages of dementia: principal component analysis approach.

Claudia Rivera-Fernández1, Nilton Custodio2, Marcio Soto-Añari1.   

Abstract

The preclinical stages of dementia include subtle neurocognitive changes that are not easily detected in standard clinical evaluations. Neuropsychological evaluation is important for the classification and prediction of deterioration in all the phases of dementia.
OBJECTIVE: Compare the neuropsychological performance in healthy older adults with subjective cognitive decline (SCD) and with mild cognitive impairment (MCI) using principal components analysis.
METHODS: We evaluated 94 older adults with a clinical protocol which included general measures of mental, emotional and functional state. The neuropsychological protocol included tasks of memory, executive function, attention, verbal fluency and visuoconstructional abilities. We used principal component analysis (PCA) to reduce variables´ dimensionality on neuropsychological evaluation.
RESULTS: 33(35%) participants had a normal cognitive function, 35(37%) had subjective cognitive decline and 26(28%) had a mild cognitive impairment. The PCA showed seven factors: processing speed, memory, visuoconstruction, verbal fluency and executive components of cognitive flexibility, inhibitory control and working memory. ANOVA had shown significant differences between the groups in the memory (F=4.383, p=0.016, η2p=0.087) and visuoconstructional components (F=5.395, p=0.006, η2p=0.105). Post hoc analysis revealed lower memory scores in MCI than SCD participants and in visuospatial abilities between MCI and SCD and MCI and Normal participants.
CONCLUSIONS: We observed differentiated cognitive profiles among the participants in memory and visuoconstruction components. The use of PCA in the neuropsychological evaluation could help to make a differentiation of cognitive abilities in preclinical stages of dementia.

Entities:  

Keywords:  cognitive dysfunction; mild cognitive impairment; neuropsychology; principal component analysis; subjective cognitive decline

Year:  2021        PMID: 34345360      PMCID: PMC8283881          DOI: 10.1590/1980-57642021dn15-020006

Source DB:  PubMed          Journal:  Dement Neuropsychol        ISSN: 1980-5764


  40 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Methodology for the development of normative data for ten Spanish-language neuropsychological tests in eleven Latin American countries.

Authors:  Joan Guàrdia-Olmos; Maribel Peró-Cebollero; Diego Rivera; Juan Carlos Arango-Lasprilla
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

3.  When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.

Authors:  Justin E Karr; Raquel B Graham; Scott M Hofer; Graciela Muniz-Terrera
Journal:  Psychol Aging       Date:  2018-03

Review 4.  Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis.

Authors:  A J Mitchell; H Beaumont; D Ferguson; M Yadegarfar; B Stubbs
Journal:  Acta Psychiatr Scand       Date:  2014-09-13       Impact factor: 6.392

5.  Principal components analysis of agitation outcomes in Alzheimer's disease.

Authors:  Jerome A Yesavage; Joy L Taylor; Leah Friedman; Paul B Rosenberg; Laura C Lazzeroni; Jeannie-Marie S Leoutsakos; Lisa M Kinoshita; Mark J Perlow; Cynthia A Munro; D P Devanand; Lea T Drye; Jacobo E Mintzer; Bruce G Pollock; Anton P Porsteinsson; Lon S Schneider; David M Shade; Daniel Weintraub; Constantine G Lyketsos; Art Noda
Journal:  J Psychiatr Res       Date:  2016-04-16       Impact factor: 4.791

Review 6.  The characterisation of subjective cognitive decline.

Authors:  Frank Jessen; Rebecca E Amariglio; Rachel F Buckley; Wiesje M van der Flier; Ying Han; José Luis Molinuevo; Laura Rabin; Dorene M Rentz; Octavio Rodriguez-Gomez; Andrew J Saykin; Sietske A M Sikkes; Colette M Smart; Steffen Wolfsgruber; Michael Wagner
Journal:  Lancet Neurol       Date:  2020-01-17       Impact factor: 44.182

7.  Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score.

Authors:  Yen Ying Lim; Peter J Snyder; Robert H Pietrzak; Albulene Ukiqi; Victor L Villemagne; David Ames; Olivier Salvado; Pierrick Bourgeat; Ralph N Martins; Colin L Masters; Christopher C Rowe; Paul Maruff
Journal:  Alzheimers Dement (Amst)       Date:  2015-12-12

Review 8.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

9.  Feature Binding Deficits in Subjective Cognitive Decline and in Mild Cognitive Impairment.

Authors:  Alexander Koppara; Ingo Frommann; Alexandra Polcher; Mario A Parra; Wolfgang Maier; Frank Jessen; Thomas Klockgether; Michael Wagner
Journal:  J Alzheimers Dis       Date:  2015-09-24       Impact factor: 4.472

10.  Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention.

Authors:  Philip S Insel; Elizabeth C Mormino; Paul S Aisen; Wesley K Thompson; Michael C Donohue
Journal:  Brain Commun       Date:  2020-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.